BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15871513)

  • 21. Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas.
    Ludwig HC; Feiz-Erfan I; Bockermann V; Behnke-Mursch J; Schallock K; Markakis E
    Anticancer Res; 2000; 20(1A):299-304. PubMed ID: 10769671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of nordihydroguaiaretic acid on endothelial cell migration induced by glioma cells].
    Sun H; Bian X; Chen Y; Shi J
    Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):30-3. PubMed ID: 11866889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A.
    Lamszus K; Ulbricht U; Matschke J; Brockmann MA; Fillbrandt R; Westphal M
    Clin Cancer Res; 2003 Apr; 9(4):1399-405. PubMed ID: 12684411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
    Riedel F; Götte K; Li M; Hörmann K; Grandis JR
    Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy.
    Riedel F; Götte K; Hörmann K; Grandis JR
    Adv Otorhinolaryngol; 2005; 62():103-20. PubMed ID: 15608422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation.
    Szentirmai O; Baker CH; Bullain SS; Lin N; Takahashi M; Folkman J; Mulligan RC; Carter BS
    J Neurosurg; 2008 May; 108(5):979-88. PubMed ID: 18447716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
    Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and culture of microvascular endothelial cells from gliomas of different WHO grades.
    Miebach S; Grau S; Hummel V; Rieckmann P; Tonn JC; Goldbrunner RH
    J Neurooncol; 2006 Jan; 76(1):39-48. PubMed ID: 16155723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts.
    Falchetti ML; Mongiardi MP; Fiorenzo P; Petrucci G; Pierconti F; D'Agnano I; D'Alessandris G; Alessandri G; Gelati M; Ricci-Vitiani L; Maira G; Larocca LM; Levi A; Pallini R
    Int J Cancer; 2008 Mar; 122(6):1236-42. PubMed ID: 18027853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of estrogen receptor-related antigen in initiating the growth of human glioma cells.
    Khalid MH; Shibata S; Furukawa K; Nadel A; Ammerman MD; Caputy AJ
    J Neurosurg; 2004 May; 100(5):923-30. PubMed ID: 15137610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma.
    Huang M; Liu T; Ma P; Mitteer RA; Zhang Z; Kim HJ; Yeo E; Zhang D; Cai P; Li C; Zhang L; Zhao B; Roccograndi L; O'Rourke DM; Dahmane N; Gong Y; Koumenis C; Fan Y
    J Clin Invest; 2016 May; 126(5):1801-14. PubMed ID: 27043280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The angiopoietin 1/angiopoietin 2 balance as a prognostic marker in primary glioblastoma multiforme.
    Sie M; Wagemakers M; Molema G; Mooij JJ; de Bont ES; den Dunnen WF
    J Neurosurg; 2009 Jan; 110(1):147-55. PubMed ID: 18991494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients.
    Takano S; Yoshii Y; Kondo S; Suzuki H; Maruno T; Shirai S; Nose T
    Cancer Res; 1996 May; 56(9):2185-90. PubMed ID: 8616870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.
    Berkman RA; Merrill MJ; Reinhold WC; Monacci WT; Saxena A; Clark WC; Robertson JT; Ali IU; Oldfield EH
    J Clin Invest; 1993 Jan; 91(1):153-9. PubMed ID: 8380810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor.
    Koren B; Weisz A; Fischer L; Gluzman Z; Preis M; Avramovitch N; Cohen T; Cosset FL; Lewis BS; Flugelman MY
    Cardiovasc Revasc Med; 2006; 7(3):173-8. PubMed ID: 16945825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature.
    Le Ricousse-Roussanne S; Barateau V; Contreres JO; Boval B; Kraus-Berthier L; Tobelem G
    Cardiovasc Res; 2004 Apr; 62(1):176-84. PubMed ID: 15023564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.
    Langenkamp E; Zhang L; Lugano R; Huang H; Elhassan TE; Georganaki M; Bazzar W; Lööf J; Trendelenburg G; Essand M; Pontén F; Smits A; Dimberg A
    Cancer Res; 2015 Nov; 75(21):4504-16. PubMed ID: 26363010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells.
    Rahaman SO; Harbor PC; Chernova O; Barnett GH; Vogelbaum MA; Haque SJ
    Oncogene; 2002 Dec; 21(55):8404-13. PubMed ID: 12466961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme.
    Bacher M; Schrader J; Thompson N; Kuschela K; Gemsa D; Waeber G; Schlegel J
    Am J Pathol; 2003 Jan; 162(1):11-7. PubMed ID: 12507885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.